Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Organisation › Details

Almirall S.A. (Spanish Stock Exchange: ALM)

Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient’s needs through science to improve their lives. Our Noble Purpose is at the core of our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. The company, founded in 1943 and headquartered in Barcelona, is publically traded on the Spanish Stock Exchange and is a member of the IBEX 35 (ticker: ALM). Throughout its 77-year history, Almirall has retained a strong focus on the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in over 70, through 13 subsidiaries, with about 1,800 employees. Total revenues in 2019 were 908.4 million euros. *


Period Start 2009-01-01 renamed
  Group Almirall (Group)
  Predecessor Laboratorios Almirall S.A.
Products Industry pharmaceutical
  Industry 2 dermatic
Persons Person Nazzi, Gianfranco (Almirall 202105– CEO before Teva Pharmaceuticals + AstraZeneca + GSK + Eli Lilly)
  Person 2 McClellan, Michael (Mike) (Teva 201711– CFO before Interim CFO before Sanofi)
Region Region Barcelona
  Country Spain (España)
  Street 151 Ronda General Mitre
  City 08022 Barcelona
  Tel +34-932-913-000
    Address record changed: 2020-12-02
Basic data Employees F: 1,001 to 5,000 (2021-02-03)
  Currency EUR
  Annual sales 908,400,000 (revenues, total, consolidated (2019) 2019-12-31)
  Profit 106,000,000 (2019-12-31)
  Cash 117,400,000 (2019-12-31)
    * Document for »About Section«: Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO".
Record changed: 2023-07-10


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Almirall (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Healthtech Company Mika 650x300px

» top